Joe Patel

VP Head of Discovery at nexo therapeutics

Professional Overview

Joe Patel is an accomplished pharmaceutical executive with extensive expertise in structural biology, biochemistry, and biophysics. As the VP Head of Discovery at nexo therapeutics, he leads a team of scientists focused on accelerating the discovery and development of novel therapeutics.

Experience Summary

Current Role

In his current role as VP Head of Discovery at nexo therapeutics, Joe is responsible for overseeing the company's discovery efforts, including target identification, hit-to-lead, and lead optimization activities. He leverages his deep scientific expertise and cross-functional leadership experience to drive the advancement of nexo's pipeline and contribute to the company's overall strategic direction.

Career Progression

Prior to joining nexo, Joe held several senior leadership positions in the pharmaceutical industry. As the Vice President of Structural Biology at Treeline Biosciences, he led a team of scientists in the development of innovative small-molecule therapies. Before that, he served as the Senior Director of Biochemistry, Biophysics, and Crystallography at C4 Therapeutics, where he played a pivotal role in the company's drug discovery efforts. Earlier in his career, Joe held various roles at AstraZeneca, including Team Leader for FBLG Chemistry and Fragment-Based Lead Generation Specialist, as well as a Senior Research Associate position at Astex Pharmaceuticals.

Academic Background

Joe holds a Ph.D. in Structural Biology from the University of Cambridge, where he specialized in the development of novel biophysical techniques for the study of protein-ligand interactions.

Areas of Expertise

• Structural biology, biochemistry, and biophysics

• Fragment-based drug discovery and lead optimization

• Target identification and validation

• Cross-functional team leadership and collaboration

• Strategic planning and decision-making

Professional Impact

Throughout his career, Joe has made significant contributions to the pharmaceutical industry. He has authored numerous peer-reviewed publications and presented his work at various scientific conferences. His expertise in the application of biophysical techniques to drug discovery has been instrumental in the advancement of several clinical-stage programs at his previous employers.

Conclusion

With his deep scientific knowledge, proven track record of success, and strong leadership capabilities, Joe Patel is well-positioned to drive the discovery and development of innovative therapeutics at nexo therapeutics. His passion for advancing the field of structural biology and its application to drug discovery makes him a valuable asset to the company and the industry as a whole.